AU Patent
AU2020338979B2 — Smart oscillating positive expiratory pressure device
Assigned to Trudell Medical International · Expires 2025-09-25 · 1y expired
What this patent protects
A respiratory therapy device having a diagonal feedback array, and methods for the user thereof.
USPTO Abstract
A respiratory therapy device having a diagonal feedback array, and methods for the user thereof.
Drugs covered by this patent
- Cutivate (FLUTICASONE PROPIONATE) · Teva Pharm
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.